Updated: 28-Oct-26 16:48 ET

Upgrades
Company	Ticker	Brokerage Firm	Ratings Change	Price Target
Softbank	SFTBY	Jefferies	Underperform » Hold
Sun Life	SLF	Scotiabank	Sector Perform » Sector Outperform
Texas Instruments	TXN	DZ Bank	Sell » Hold	$300
Pentair	PNR	BNP Paribas Exane	Underperform » Neutral	$65
Chemed	CHE	Jefferies	Hold » Buy	$620
Downgrades
Company	Ticker	Brokerage Firm	Ratings Change	Price Target
Boston Scientific	BSX	JP Morgan	Overweight » Neutral	$46
Equinor	EQNR	DZ Bank	Buy » Hold
Seagate Tech	STX	Summit Insights	Buy » Hold
Datavault AI	DVLT	Maxim Group	Buy » Hold
Enphase Energy	ENPH	Roth Capital	Buy » Neutral	$30
Manulife Financial	MFC	Scotiabank	Sector Outperform » Sector Perform
Xylem	XYL	JP Morgan	Overweight » Neutral	$90
Whirlpool	WHR	Stifel	Hold » Sell	$20
Simply Good Foods	SMPL	Jefferies	Buy » Hold	$11
Kosmos Energy	KOS	Jefferies	Buy » Hold	$2.90
F5 Networks	FFIV	Piper Sandler	Overweight » Neutral	$461
Enphase Energy	ENPH	Oppenheimer	Outperform » Perform
Dyne Therapeutics	DYN	Oppenheimer	Outperform » Perform	$15
Coverage Initiated
Company	Ticker	Brokerage Firm	Ratings Change	Price Target
Procore Technologies	PCOR	Griffin Securities	Buy	$82
C4 Therapeutics	CCCC	Lake Street	Buy	$11
Anfield Energy	AEC	Roth Capital	Buy	$5
Cavco Industries	CVCO	Northland Capital	Outperform	$650
Alignment Healthcare	ALHC	Needham	Hold
Clover Health	CLOV	Needham	Buy	$6
MSG Rangers Corp	MSGR	Guggenheim	Buy	$278
Silicon Motion	SIMO	China Renaissance	Buy	$300
Spero Therapeutics	SPRO	Cantor Fitzgerald	Overweight	$6
Lakewood-Amedex Biotherapeutics	LABT	H.C. Wainwright	Buy	$3

(a) Brokerage firm initiating coverage participated in underwriting the recent IPO.

(b) Brokerage firm resumes coverage.

(c) Brokerage firm participated in the secondary offering.

* This list of reiterations/target changes is not comprehensive.